Dufès C - Search Results

1

Enhanced gene expression in the brain following intravenous administration of lactoferrin-bearing polypropylenimine dendriplex.

Somani S, Robb G, Pickard BS, Dufès C. Somani S, et al. Among authors: dufes c. J Control Release. 2015 Nov 10;217:235-42. doi: 10.1016/j.jconrel.2015.09.003. Epub 2015 Sep 8. J Control Release. 2015. PMID: 26362697 Free article.

2

Preferential liver gene expression with polypropylenimine dendrimers.

Schatzlein AG, Zinselmeyer BH, Elouzi A, Dufes C, Chim YT, Roberts CJ, Davies MC, Munro A, Gray AI, Uchegbu IF. Schatzlein AG, et al. Among authors: dufes c. J Control Release. 2005 Jan 3;101(1-3):247-58. doi: 10.1016/j.jconrel.2004.08.024. J Control Release. 2005. PMID: 15588909

3

Tumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles.

Fu JY, Blatchford DR, Tetley L, Dufès C. Fu JY, et al. Among authors: dufes c. J Control Release. 2009 Dec 3;140(2):95-9. doi: 10.1016/j.jconrel.2009.08.017. Epub 2009 Aug 23. J Control Release. 2009. PMID: 19709637

4

Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA.

Koppu S, Oh YJ, Edrada-Ebel R, Blatchford DR, Tetley L, Tate RJ, Dufès C. Koppu S, et al. Among authors: dufes c. J Control Release. 2010 Apr 19;143(2):215-21. doi: 10.1016/j.jconrel.2009.11.015. Epub 2009 Nov 26. J Control Release. 2010. PMID: 19944722

5

Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polyethylenimine polyplex.

Aldawsari H, Raj BS, Edrada-Ebel R, Blatchford DR, Tate RJ, Tetley L, Dufès C. Aldawsari H, et al. Among authors: dufes c. Nanomedicine. 2011 Oct;7(5):615-23. doi: 10.1016/j.nano.2011.01.016. Epub 2011 Feb 17. Nanomedicine. 2011. PMID: 21333755

6

Novel tocotrienol-entrapping vesicles can eradicate solid tumors after intravenous administration.

Fu JY, Zhang W, Blatchford DR, Tetley L, McConnell G, Dufès C. Fu JY, et al. Among authors: dufes c. J Control Release. 2011 Aug 25;154(1):20-6. doi: 10.1016/j.jconrel.2011.04.015. Epub 2011 Apr 22. J Control Release. 2011. PMID: 21539872

7

Enhanced gene expression in tumors after intravenous administration of arginine-, lysine- and leucine-bearing polypropylenimine polyplex.

Aldawsari H, Edrada-Ebel R, Blatchford DR, Tate RJ, Tetley L, Dufès C. Aldawsari H, et al. Among authors: dufes c. Biomaterials. 2011 Sep;32(25):5889-99. doi: 10.1016/j.biomaterials.2011.04.079. Epub 2011 May 18. Biomaterials. 2011. PMID: 21596431

8

Tumor regression following intravenous administration of a tumor-targeted p73 gene delivery system.

Lemarié F, Croft DR, Tate RJ, Ryan KM, Dufès C. Lemarié F, et al. Among authors: dufes c. Biomaterials. 2012 Mar;33(9):2701-9. doi: 10.1016/j.biomaterials.2011.12.019. Epub 2011 Dec 24. Biomaterials. 2012. PMID: 22200536

9

Antitumor activity of the tea polyphenol epigallocatechin-3-gallate encapsulated in targeted vesicles after intravenous administration.

Lemarié F, Chang CW, Blatchford DR, Amor R, Norris G, Tetley L, McConnell G, Dufès C. Lemarié F, et al. Among authors: dufes c. Nanomedicine (Lond). 2013 Feb;8(2):181-92. doi: 10.2217/nnm.12.83. Epub 2012 Aug 14. Nanomedicine (Lond). 2013. PMID: 22891867 Free article.

10

Transferrin and the transferrin receptor for the targeted delivery of therapeutic agents to the brain and cancer cells.

Dufès C, Al Robaian M, Somani S. Dufès C, et al. Ther Deliv. 2013 May;4(5):629-40. doi: 10.4155/tde.13.21. Ther Deliv. 2013. PMID: 23647279 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters